Maternal metabolic phenotype and risk of down syndrome: Beyond genetics
Author:
- 26 November 2003
- journal article
- invited comment
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 127A (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndromeAmerican Journal of Medical Genetics Part A, 2003
- Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjectsCarcinogenesis, 2003
- Prevalence of trisomy 21 following folic acid food fortificationAmerican Journal of Medical Genetics Part A, 2003
- Mutações no gene da metilenotetrahidrofolato redutase e síndrome de DownCadernos de Saude Publica, 2002
- Maternal Folate Polymorphisms and the Etiology of Human NondisjunctionThe American Journal of Human Genetics, 2001
- Prevention of Neural-Tube Defects with Folic Acid in ChinaNew England Journal of Medicine, 1999
- Micronucleus frequency in human lymphocytes is related to plasma vitamin B12 and homocysteineMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1999
- 677right-arrowCT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in TurkeyArchives of Disease in Childhood - Fetal and Neonatal Edition, 1998
- Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defectsHuman Genetics, 1997
- Down's syndrome and its association with Alzheimer's diseaseActa Psychiatrica Scandinavica, 1988